Agenda

Agenda from MediSens 2018

Please note this is the agenda from a past event, run in February 2018. Watch this space for the next agenda to be announced…

Why attend these industry-leading conferences? 

Download the MediSens Agenda PDF from 2018

Download link >>

Full agenda from 2018 (past event)

Sample agenda for reference only – not regularly updated. For the complete current agenda, please see above or complete the form above to download the PDF.

Day One

• Clinical panel; assessing the unmet needs in oncological imaging
  • Perspectives from radiology, oncology and medical physics
  • Current challenges and performance issues with medical imagers
  • Where should R&D teams focus their efforts for improved results?

• Nuclear imaging; a state of the industry overview
  • The move to solid state detectors and readout systems
  • A wider acceptance of quantitative SPECT / CT
  • The influence of time-of-flight on PET / CT performance
  • The expansion of hybrid imaging to include PET / MRI and potentially SPECT / MRI
  • Future directions: pushing the boundaries of resolution and sensitivity

• Increasing clinical sensitivity and specificity through hybrid imaging
  • Why hybrid imaging is needed
  • Hybrid imaging technologies
  • Clinical advantages of hybrid imaging
  • Quantitative advantages of hybrid imaging

• A Multimodality Hybrid Gamma-Optical Camera for Intraoperative Imaging
  • Hybrid imaging – combined optical and gamma imaging
  • Camera design and application areas
  • Phantom and preclinical imaging
  • Images from a current clinical evaluation
  • Future developments including combined gamma and Near Infra-red imaging

• Optical molecular medical imaging; lung endoscopy
  • Detail of the Proteus Project; Lighting up the Lung, Detecting Disease
  • Develop a revolutionary technology that will provide quick in situ, in vivo diagnoses and management of lung diseases in the clinic

• What unmet radiological needs could be addressed by PET/MR?
  • Innovative applications for PET/MR in clinical routine
  • Logistical / economical challenges for PET/MR
  • PET/MR for “virtual biopsy”: multiparametric multimodal imaging as a prognostic and predictive biomarker
• Recent Developments in Photon-Counting Computed Tomography
  • Use of photon-counting X-ray detectors proposed to further improve the diagnostic value of this modality
  • Advantages in contrast enhancement and a considerable reduction in patient dose, material-identification and K-edge imaging
  • Presentation of results from two research prototype scanners with photon-counting detector, installed in near-clinical environments
  • Demonstration of the clinical benefits of this new technology
• CMOS-based mammography detector
  • Latest results
  • Discussion of ideas to use the strength of this technology for future diagnosis
• NHS England’s diagnostic perspective on AI and machine learning, wider issues and unmet needs
• The role of PET image reconstruction in diagnosis and treatment of cancer
  • Elucidating the role of PET imaging in the new era of radiomics and speculating the obstacles towards this direction
  • Exploring dynamic PET and image reconstruction techniques to make PET imaging a more accurate and precise molecular imaging modality
  • Understanding the most recent advancements in PET physics which have been or expected to be translated in the clinic
  • Discussion on the pioneering research activities that aim at revolutionising the field of clinical molecular imaging
• Advances in computer-aided diagnosis; how should radiologists and oncologists embrace this technology?
  • New developments in the affordability and reliability of CAD and automated image analysis
  • Current use cases in the assessment of colorectal polyps on CT virtual colonography, lung nodule analysis and
  • MRI for breast, prostate and many other cancers
  • Further potential uses include quantification of metastatic disease and more objective follow-up.
  • Exploring wide variation in sensitivity and PPV of commercially available software and usefulness limitations
  • Tips for the practical use of CAD

• Keynote: Image-guided radiotherapy
• Keynote: Precision imaging requirements for proton therapy

Day Two

• Clinical panel; challenges in imaging for treatment
  • Radiography and clinical wish-list for image quality
  • Unmet needs in imaging for treatment
  • Bridging the gap between clinical and technical metrics in device evaluation
• CT texture analysis in Non-Small Cell Lung Cancer
  • Can a standard CT scan give greater information for the management of patients with lung cancer?
  • Using texture analysis to analyse a small region of interest of lung tissue to see if it could predict fitness for radical radiotherapy
• The need for standardisation and optimisation of imaging and dosimetry in molecular radiotherapy
  • A review of common and emerging MRT treatments
  • Discussion of their clinical and metrological challenges
• Developments in contrast media and the impact on imaging technology
  • Contrast agent, why do we need them? General definition
  • Diffuse contrast agent (examples for ultrasound, MRI, DNP-MRI and PET)
  • Targeted contrast agent; focused on the antibody linked contrast agent (example of PSMA for multi-modalities)
  • Nanoparticles (examples for ultrasound, MRI and PET)
• Be inspired by optical technologies for new X-ray imaging modalities
  • Time-of-flight X-ray imaging enabled by carbon-nanotube based cold-cathode X-ray sources
  • Direct X-ray photon detection with high energy resolution through semiconductors and perovskites
  • Dark-field X-ray imaging based on phase contrast techniques
  • X-ray spectroscopy for element-sensitive X-ray radiography and CT imaging
  • Triboluminescence for X-ray photon generation
• How will sensor technology impact the medical robots of the future?
  • Introduction of the technologies behind the different types of medical robots (surgical robots, exoskeleton, micro-robots…),
  • Detailing the current technologies limits and main challenges and how it might evolve in the future
• Closing keynote address: Latest advances in image-guided surgery and intervention

The organisers reserve the right to alter or amend agenda items without notice, though shall endeavour to ensure the topics, themes and sessions remain as stable as possible from the point of agenda announcement.

While it is unlikely the event will change markedly, it is inevitable that a very small number of sessions will change from what we are able to publish even at the event due to unforeseen or unavoidable circumstances, particularly for those sessions hosted by practicing clinicians.